Decades of Support for Government Biomedical Organizations

IMS builds the data systems, platforms, and infrastructure behind some of the nation's most critical biomedical research programs. For more than five decades, we've supported NIH, CDC, and NCI initiatives at scale by enabling secure, high quality data to drive discovery and public health impact.

What We Provide

Expertise & capabilities developed for government efforts.

We provide full lifecycle support for large scale biomedical research programs, from data coordination to platform development and compliance.

Browse All Capabilities

Data Management

  • Data coordinating center services
  • Data acquisition, cleaning, linkage, harmonization, and transformation

Statistical Programming

  • Scientific reporting & manuscript preparation
  • Study design method and model development
  • Dataset preparation and Analytical process documentation

Data Standards & Quality

  • SOP-driven quality assurance & quality control
  • Documentation control for standards

Web Tools & Platforms

  • Design & development
  • Request & dissemination platforms
  • Advanced search and discovery tools
  • Software development

Program Management

  • Analytic reporting and metrics tracking
  • Task tracking platforms
  • Working group & stakeholder coordination
  • Promotional activities
  • Help desk staffing

Infrastructure & Compliance

  • FIMSA-compliant hosting & computing
  • CADR compliance
  • VPATs for Section 508
  • SOC2 audits
  • HIPAA & HITECH
  • 21 CFR Part 11

Who We Serve

Trusted by federal health agencies.

IMS has partnered with federal agencies across multiple generations of contracts, supporting mission-critical programs through recompetes, task orders, and evolving acquisition strategies. Our familiarity with federal contracting processes helps ensure smooth program execution, strong stewardship of government resources, and long-term continuity.

IMS has supported the NCI for decades, with long-standing partnerships across its largest research divisions.

  • Built hundreds of websites, data systems, and research tools
  • Developed SEER*Stat and Joinpoint software, used worldwide
  • Contributed to 1,000+ publications
  • Supports the Annual Report to the Nation on the Status of Cancer

We also developed and manage the Surveillance, Epidemiology, and End Results program's Data Management System (SEER*DMS) supporting cancer registry operations covering 48% of the U.S. population. We collaborate with non-profits like the North American Association of Central Cancer Registries (NAACCR) and the International Society for Biological and Environmental Repositories (ISBER).

Explore NCI Support

IMS supports multiple NIH institutes in addition to NCI through research platforms and analytics.

  • BioLINCC
    Data and specimen sharing platform for the National Heart, Lung, and Blood Institute (NHLBI)
  • BioShare
    Biobank material and data request platform for the National Institute on Aging the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute of Environmental Health Sciences (NIEHS), and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • Biological Specimen Inventory (BSI)
    Laboratory Information Management System (LIMS) used by five NIH institutes including the National Institute of Allergy and Infectious Diseases (NIAID)

We also provide analytical services and publication support across NIH-funded research.

Explore NIH Support

IMS supports over 100 grantee organizations through data systems and software for CDC screening programs.

  • 30+ years as the data management center for the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) and the Colorectal Cancer Control Program (CRCCP)
  • Data integration, validation, and secure infrastructure
  • Contributions to nearly 20 research publications.
Explore CDC Tools

Contract Vehicles

IMS holds an active federal contract vehicle through GSA Advantage, providing streamlined access to our services.

Beyond Federal

IMS extends its expertise beyond federal programs, partnering with pharmaceutical organizations, cancer registries, and non-profits to solve complex data and research challenges.

Cancer Registries

IMS supports national, state, and regional cancer registries, including development of SEER*DMS, the data management system used across SEER and non-SEER programs.

Pharmaceutical Research Groups

IMS helps pharmaceutical teams advance real-world evidence (RWE) and data analytics initiatives with training in SEER and Joinpoint tools for HEOR, statistical support, and more.

Non-profit Organizations

IMS collaborates with leading nonprofit organizations to advance cancer research, data standards, and biobanking practices.